A 25-year-old female comes to her obstetrician’s office for a prenatal visit. She has a transvaginal ultrasound that correlates with her last menstrual period and dates her pregnancy at 4 weeks. She has no complaints except some nausea during the morning that is improving. She comments that she has had some strange food cravings, but has no issues with eating a balanced diet. Her BMI is 23 kg/m^2 and she has gained 1 pound since the start of her pregnancy. She is curious about her pregnancy and asks the physician what her child is now able to do. Which of the following developments is expected of the fetus during this embryological phase?

Cardiac activity visible on ultrasound

A 24-year-old woman comes to the physician for preconceptional advice. She has been married for 2 years and would like to conceive within the next year. Menses occur at regular 30-day intervals and last 4 days with normal flow. She does not smoke or drink alcohol and follows a balanced diet. She takes no medications. She is 160 cm (5 ft 3 in) tall and weighs 55 kg (121 lb); BMI is 21.5 kg/m2. Physical examination, including pelvic examination, shows no abnormalities. She has adequate knowledge of the fertile days of her menstrual cycle. Which of the following is most appropriate recommendation for this patient at this time?

Begin high-dose vitamin A supplementation

Begin vitamin B12 supplementation

A 34-year-old gravida 2 para 1 woman at 16 weeks gestation presents for prenatal care. Her prenatal course has been uncomplicated. She takes no medications besides her prenatal vitamin which she takes every day, and she has been compliant with routine prenatal care. She has a 7-year-old daughter who is healthy. The results of her recent quadruple screen are listed below: AFP: Low hCG: Low Estriol: Low Inhibin-A: Normal Which of the following is the most appropriate next step to confirm the diagnosis?

Ultrasound for nuchal translucency

Neural tube defects for USMLE Step 1: High-Yield Pediatrics Lessons

NTD Embryology - The Great Closure

Neurulation (Week 3-4): Neural plate folds into the neural tube. Closure begins cervically, extending cranially and caudally.
- Anterior (Rostral) Neuropore: Closes ~Day 25. Failure → Anencephaly.
- Posterior (Caudal) Neuropore: Closes ~Day 27-28. Failure → Spina Bifida.

Neural Tube Closure Timeline: Mouse vs. Human

Folic Acid's Role: Essential for the Methionine-Homocysteine pathway, crucial for DNA synthesis and cell division.
- Prevention Dosage:
  - Low-risk: 400 mcg/day pre-conceptionally.
  - High-risk (e.g., prior NTD): 4 mg/day.

⭐ Exam Fact: Neural tube closure is complete by the 4th week post-conception, often before a woman realizes she is pregnant. This underscores the critical need for pre-conceptional folate supplementation.

NTD Spectrum - Open & Shut Cases

Neural tube defects (NTDs) are classified as open (exposed neural tissue) or closed (skin-covered).

Defect	Common Location	Sac Contents	Skin Cover	Key Clinical Signs
Spina Bifida Occulta	Lumbosacral	None	Yes (intact)	Tuft of hair, dimple, lipoma
Meningocele	Lumbosacral	Meninges + CSF	Yes (thin)	Visible cystic swelling
Myelomeningocele	Lumbosacral	Cord + Meninges + CSF	No (open)	Neurological deficits below lesion
Anencephaly	Cranial	-	No	Absence of forebrain/skull
Encephalocele	Occipital	Brain + Meninges + CSF	Yes	Visible sac on the skull

⭐ Exam Favourite: Myelomeningocele is almost universally associated with Arnold-Chiari II malformation, causing hydrocephalus.

Clinical Clues - Finding the Flaw

Focuses on prenatal diagnosis, primarily through maternal screening and ultrasound.

Maternal Serum Screening (Triple/Quad Screen) at 15-20 weeks:
- ↑ Alpha-fetoprotein ($AFP$): Open neural tube allows fetal protein to leak into amniotic fluid and maternal circulation.
- ↑ Acetylcholinesterase ($AChE$) in amniotic fluid: More specific than AFP.
Level II Ultrasound Findings:
- Anencephaly: 'Frog-eye' or 'Mickey Mouse' sign due to absent cranial vault.
- Spina Bifida (Chiari II Malformation):
  - 'Lemon sign': Scalloping of frontal bones.
  - 'Banana sign': Cerebellum is pulled caudally, obliterating the cisterna magna.

⭐ High-Yield Fact: While elevated maternal serum $AFP$ is a sensitive screening marker, the presence of Acetylcholinesterase ($AChE$) in the amniotic fluid is highly specific for an open NTD.

Ultrasound of Chiari II malformation with lemon/banana signs

Complications & Care - The Aftermath

Immediate Complications:
- Hydrocephalus: Blockage of CSF flow; occurs in >80% of cases.
- Arnold-Chiari II Malformation: Universal finding in myelomeningocele; cerebellar vermis & medulla herniate through foramen magnum.
- Neurogenic Bladder/Bowel: Risk of incontinence, retention, and recurrent UTIs.
- Motor/Sensory Deficits: Flaccid paralysis, lack of sensation below the lesion level.
Management Principles:
- Surgical Closure: Ideally within 24-72 hours to minimize infection risk.
- Ventriculoperitoneal (VP) Shunt: Placed to manage progressive hydrocephalus.

⭐ Exam Pearl: The level of motor paralysis is the single most useful predictor of ambulation potential.

Ventriculoperitoneal (VP) Shunt Diagram shunt placement for hydrocephalus)

Folic acid supplementation is the most crucial preventive measure; dose varies with risk (0.4 mg vs 4 mg).

Maternal serum alpha-fetoprotein (MSAFP) is the key screening marker, elevated in open NTDs.

Ultrasound is the primary diagnostic tool for antenatal detection.

Anencephaly presents with polyhydramnios and a characteristic "frog-eye" appearance; it is lethal.

Myelomeningocele is the most common severe form, strongly associated with Arnold-Chiari II malformation and hydrocephalus.

Spina bifida occulta is the mildest form, often marked only by a sacral dimple or hair tuft.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play